With the close of this investment round, Tursiop plans to establish office and laboratory spaces, continue research and product development, and begin the FDA approval process.
This is JumpStart's 41st investment in its 30th company. Other healthcare companies in JumpStart's portfolio include AcelleRX Therapeutics, AnalizaDx, CardioInsight Technologies, CerviLenz, Great Lakes Pharmaceuticals, Synapse Biomedical and Telerad Express.
About Tursiop Technologies, LLC
Tursiop Technologies is developing revolutionary MRI coil devices utilizing proprietary nanotechnology, which will produce higher image quality and faster scan times resulting in a significant boost of the functional capabilities of any installed MRI system. Tursiop-generated imaging enhancements will apply across the entire range of MRI system field strengths, from low-field to high-field systems. Increased diagnostic competency will lead to improved patient outcomes and open the doors to new therapeutic opportunities within the areas of interventional, intra-operative and functional MRI and molecular imaging.
About RMS Management
RMS Management is an integrated family office that was formed in 1991 and is comprised of a diverse group of individuals and institutions providing financial and personal services to the founding families of a publicly traded real estate company. The company strives to enhance the professional and personal goals and objectives of every generation of the Ratner, Miller and Shafran families.
About JumpStart Inc.
JumpStart ( http://www.jumpstartinc.org ) accelerates the growth of innovative
early-stage businesses and ideas into venture-ready compani
|SOURCE JumpStart Inc.|
Copyright©2008 PR Newswire.
All rights reserved